“…In addition, the underlying disease, the conditioning regimen, as well as the toxicity of the treatment, acute GVHD and chronic pulmonary complications may be related to mortality [35,36]. The incidence of acute GVHD increases when HSCT is performed with unrelated donor and the increase in the difference between the ages of donor and recipient.…”